David A. Angulo, MD

Chief Medical Officer
SCYNEXIS, Inc.
Jersey City, NJ, United States

SCYNEXIS, Inc. (Employee, Shareholder)

Presentation(s):

• 123 - Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI)

  On Demand